Please provide your email address to receive an email when new articles are posted on . As a disease that traditionally has been thought to only affect men, hemophilia has acquired the false ...

Hemophilia A and B are chronic inherited bleeding disorders that together rank as one of the most expensive chronic diseases in the United States. Factor replacement products, which are the mainstay ...

Hemophilia is much more common in males than in females. According to the CDC, an estimated 400 male babies are born with hemophilia each year in the United States. Hemophilia is a rare bleeding ...

Please provide your email address to receive an email when new articles are posted on . Patients who received prophylactic concizumab had a mean overall annualized bleeding rate of zero compared with ...

SAN DIEGO — Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer product to become the second US Food and Drug Administration (FDA) ...

There are two main types of hemophilia - Hemophilia A (due to factor VIII deficiency) and Hemophilia B (due to factor IX deficiency). They are clinically almost identical and are associated with ...

A one-time novel gene therapy can reduce the risk of excessive bleeding in people with the bleeding disorder hemophilia B, who typically would need repeat therapies to reduce their risk, according to ...

Approval of valoctocogene roxaparvovec for adults with severe hemophilia A was based on data from the global phase III GENEr8-1 study, in which the therapy reduced the average annualized bleeding rate ...

People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of a ...

FRISCO, Texas--(BUSINESS WIRE)--Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it was named one of four exclusive ...